Ascendis Pharma (NASDAQ:ASND) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.78 by 34.62 percent. This is a 212.9 percent increase over losses of $(0.93) per share from the same period last year. The company reported quarterly sales of $394.437 million which beat the analyst consensus estimate of $353.800 million by 11.49 percent. This is a 120.08 percent increase over sales of $179.223 million the same period last year.